242
Views
21
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Does long-term medication with lithium, clozapine or antidepressants prevent or attenuate dementia in bipolar and depressed patients?

, , , &
Pages 2-8 | Received 26 Sep 2005, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Joshua Hunsberger, Daniel R. Austin, Ioline D. Henter & Guang Chen. (2009) The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues in Clinical Neuroscience 11:3, pages 333-348.
Read now
Jules Angst. (2008) Bipolar disorder-methodological problems and future perspectives . Dialogues in Clinical Neuroscience 10:2, pages 129-139.
Read now

Articles from other publishers (19)

L. Ronat & A. Hanganu. (2023) Neuropsychiatric and cognitive features of major depressive disorder in aging, based on the data from the US National Alzheimer's Coordinating Center (NACC). L'Encéphale.
Crossref
Alyssa L. Wiseman, Clark A. Briggs, Ariel Peritt, Nicolas Kapecki, Daniel A. Peterson, Seong S. Shim & Grace E. Stutzmann. (2023) Lithium Provides Broad Therapeutic Benefits in an Alzheimer’s Disease Mouse Model. Journal of Alzheimer's Disease 91:1, pages 273-290.
Crossref
Seong Sool Shim, Ken Berglund & Shan Ping Yu. (2023) Lithium: An Old Drug for New Therapeutic Strategy for Alzheimer’s Disease and Related Dementia. Neurodegenerative Diseases 23:1-2, pages 1-12.
Crossref
Nobuyoshi Ishii, Takeshi Terao & Hirofumi Hirakawa. (2021) The Present State of Lithium for the Prevention of Dementia Related to Alzheimer’s Dementia in Clinical and Epidemiological Studies: A Critical Review. International Journal of Environmental Research and Public Health 18:15, pages 7756.
Crossref
Jaehyun Kim, Tae Hyon Ha, Kiwon Kim, Eun-Mi Lee, Hyekyeong Kim, Doh Kwan Kim, Hong-Hee Won, Matthew Lewis, Hyewon Lee & Woojae Myung. (2021) Atypical Antipsychotics Augmentation in Patients with Depressive Disorder and Risk of Subsequent Dementia: A Nationwide Population-Based Cohort Study. Journal of Alzheimer's Disease 80:1, pages 197-207.
Crossref
Lisha Wang, Bharti, Rajnish Kumar, Pavel F. Pavlov & Bengt Winblad. (2021) Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance. European Journal of Medicinal Chemistry 209, pages 112915.
Crossref
J. Velosa, A. Delgado, E. Finger, M. Berk, F. Kapczinski & T. Azevedo Cardoso. (2020) Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta‐analyses. Acta Psychiatrica Scandinavica 141:6, pages 510-521.
Crossref
Joyce Y.C. Chan, Karen K.L. Yiu, Timothy C.Y. Kwok, Samuel Y.S. Wong & Kelvin K.F. Tsoi. (2019) Depression and Antidepressants as Potential Risk Factors in Dementia: A Systematic Review and Meta-analysis of 18 Longitudinal Studies. Journal of the American Medical Directors Association 20:3, pages 279-286.e1.
Crossref
Rita Khoury & George T. Grossberg. (2018) Impact of Antidepressant Use on the Trajectory of Alzheimer’s Disease: Evidence, Mechanisms, and Therapeutic Implications. CNS Drugs 33:1, pages 17-29.
Crossref
Janusz K. Rybakowski. 2018. Alzheimer's Disease - The 21st Century Challenge. Alzheimer's Disease - The 21st Century Challenge.
John Moraros, Chijioke Nwankwo, Scott B. Patten & Darrell D. Mousseau. (2017) The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis. Depression and Anxiety 34:3, pages 217-226.
Crossref
James M. Prosser & Ronald R. Fieve. (2016) Patients receiving lithium therapy have a reduced prevalence of neurological and cardiovascular disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 71, pages 39-44.
Crossref
Sivan Mauer, Derick Vergne & S Nassir Ghaemi. (2014) Standard and trace-dose lithium: A systematic review of dementia prevention and other behavioral benefits. Australian & New Zealand Journal of Psychiatry 48:9, pages 809-818.
Crossref
Jules Angst. (2013) Bipolar disorders in DSM-5: strengths, problems and perspectives. International Journal of Bipolar Disorders 1:1.
Crossref
Vicent Balanzá-Martínez, Gabriel Selva, Anabel Martínez-Arán, Jos Prickaerts, José Salazar, Ana González-Pinto, Eduard Vieta & Rafael Tabarés-Seisdedos. (2010) Neurocognition in bipolar disorders—A closer look at comorbidities and medications. European Journal of Pharmacology 626:1, pages 87-96.
Crossref
Rodrigo Machado-Vieira, Husseini K Manji & Carlos A Zarate Jr. (2009) The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disorders 11, pages 92-109.
Crossref
Jules Angst. (2009) From psychoanalysis to epidemiology: autobiographical notes. Acta Psychiatrica Scandinavica 119:2, pages 87-97.
Crossref
Robert J Schloesser, Jian Huang, Peter S Klein & Husseini K Manji. (2007) Cellular Plasticity Cascades in the Pathophysiology and Treatment of Bipolar Disorder. Neuropsychopharmacology 33:1, pages 110-133.
Crossref
De-Maw Chuang & Husseini K. Manji. (2007) In Search of the Holy Grail for the Treatment of Neurodegenerative Disorders: Has a Simple Cation Been Overlooked?. Biological Psychiatry 62:1, pages 4-6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.